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Antonio Carroccio, MD3,6
OBJECTIVES: Non-celiac wheat sensitivity (NCWS) is defined as a reaction to ingested wheat after exclusion of celiac disease and
wheat allergy. As its pathogenesis is incompletely understood, we evaluated the inflammatory response in the rectal mucosa of
patients with well-defined NCWS.
METHODS: The prospective study included 22 patients with irritable bowel syndrome (IBS)-like clinical presentation, diagnosed
with NCWS by double-blind placebo-controlled challenge. Eight IBS patients not improving on wheat-free diet were used as
controls. Two weeks after oral challenge was performed with 80 grams of wheat daily, cells were isolated from rectal biopsies and
thoroughly characterized by fluorescence-activated cell sorting analysis for intracellular cytokines and surface markers.
RESULTS: Rectal biopsies from wheat-challenged NCWS patients showed that a significant mucosal CD45+ infiltrate consisted of
CD3+ and CD3− lymphocytes, with the latter spontaneously producing more interferon (IFN)-γ than IBS controls. About 30% of
IFN-γ-producing CD45+ cells were T-bet+, CD56−, NKP44−, and CD117−, defining them as a type-1 innate lymphoid cells (ILC1).
IFN-γ-producing ILC1 cells significantly decreased in 10 patients analyzed 2 weeks after they resumed a wheat-free diet.
CONCLUSIONS: These data indicate that, in patients with active NCWS, IFN-γ-producing ILC1 cells infiltrate rectal mucosa and
support a role for this innate lymphoid cell population in the pathogenesis of NCWS.
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INTRODUCTION
Non-celiac gluten sensitivity (NCGS) has attracted increasing
attention as a common cause of morbidity. NCGS is a
condition where intestinal and extraintestinal symptoms are
triggered by gluten ingestion in the absence of celiac disease
and wheat allergy, as defined by discussions held at three
different international consensus conferences.1–3
Despite the great interest in NCGS, much remains unknown
about the pathogenesis. Some studies seem to suggest that
wheat components other than gluten can cause the symp-
toms, and therefore the term “non-celiac wheat sensitivity”
(NCWS) has been proposed instead of NCGS.4,5 NCWS
pathogenesis has been attributed to very different mechan-
isms: incomplete digestion and/or absorption of fermentable
oligosacchararides and disacchararides, monosaccharides
and polyols,6 psychological effect,7 or innate or adaptive
immunity.8–11
Innate lymphoid cells (ILCs) are a new, well-characterized
population of innate immune cells, morphologically resembling
T cells and derived from an Id2-dependent common lymphoid
precursor.12–18 ILCs are divided into three major groups on the
basis of a different transcriptional control and cytokine
responsiveness and production. ILCs belonging to the group
1 include both natural killer (NK) and non-cytolytic ILC1. These
non-cytolytic ILC1 are characterized by the expression of the
transcription factor T-bet and production of interferon (IFN)-γ in
response to interleukin (IL)-12, IL,-15 and IL-18 and thus
resemble CD4+ T helper 1 cells innate counterparts.15,19–23
Group 2 ILCs are dependent on GATA3 and retinoic acid–
related orphan receptor α transcription factors for develop-
ment. They produce type-2 cytokines such as IL-13, IL-5, IL-9,
and amphiregulin in response to IL-25 and IL-33 produced
upon infection by helminth parasites, airway responsiveness,
and tissue repair.15,24 Finally, group 3 ILCs, including lymphoid
tissue cells and ILC3 cells, are under control of the retinoic
acid–related orphan receptor γt transcription factor. ILC3
produce IL-17A and IL-22 in response to IL-23 and IL-1β
produced upon infection by extracellular bacteria. They are
functionally implicated in promoting inflammation or tissue
repair, especially in the bowel.15,25–27
Recently, relevant alterations in intestinal ILCs have been
detected in patients with inflammatory bowel disease. Notably,
it has been shown that patients affected by Crohn’s disease
had an increase of IFN-γ producing ILC1 in the lamina propria
and in the intraepithelial compartment, compared with normal
controls without inflammation.26,28–30 Hence, alterations of
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ILC populations could be associated with the pathogenesis
and outcome of some human gastrointestinal diseases.
Here we show that intraepithelial IFN-γ+ ILC1 cells
are expanded in the inflamed rectal tissue of NCWS
patients but values significantly decrease after gluten
(wheat)-free diet, suggesting that intraepithelial ILC1 may
initiate IFN-γ response and contribute to the pathogenesis
of NCWS.
MATERIALS AND METHODS
Patients. We prospectively recruited adult patients with an
irritable bowel syndrome (IBS)-like clinical presentation,
according to the Rome II criteria, and a suspected diagnosis
of NCWS. Most of the patients had been referred owing
to intestinal symptoms whose onset, they reported, could
be related to wheat ingestion and most of them also had
extraintestinal symptoms. The patients were recruited
between January 2014 and January 2015 at two centers:
the Department of Internal Medicine at the University Hospital
of Palermo and the Department of Internal Medicine of the
Hospital of Sciacca.
During this period, 4400 patients with suspected NCWS
were examined, and after careful exclusion of Crohn’s disease,
immunoglobulin E (IgE)-mediated wheat allergy (testing
negative for serum-specific IgE and skin allergy tests), and
inflammatory bowel disease diagnoses, 130 of them consented
to enter one or more of our ongoing study protocols (see
Supplementary File S1). These patients underwent an elimina-
tion diet and a subsequent double-blind placebo-controlled
(DBPC) wheat challenge, using 80 g of wheat flour or rice flour
for 2 weeks; the flour was given in packets and the patients
consumed them after cooking (see Supplementary File S2).31
Sixty-one subjects tested positives to the challenge and
received a definitive diagnosis of NCWS; of these, 22 patients
(20 females, 2males, age range 23–61 years,median 32 years)
accepted to enter the present study. Table 1 shows the clinical
characteristics of the patients enrolled in this study. These
patients underwent rectal endoscopy with multiple mucosal
biopsies at 5–15 cm from the anal verge at the end of the DBPC
challenge, when they reported the reappearance of the
symptoms. Ten patients who had reacted to the wheat
challenge consented to rectoscopy and mucosal biopsies
analysis 2 weeks after they resumed a wheat-free diet,
when they again became asymptomatic. Of these, only 5
cases belonged to the already studied 22 patients on wheat
challenge, while 5 caseswere analyzed only 2 weeks after they
resumed a wheat-free diet. Exclusion criteria were: (a) self-
exclusion of wheat from the diet and refusal to reintroduce
it, before entering the study; and (b) other “organic” gastro-
intestinal diseases.
As controls, we included eight subjects (seven females,
one male) with IBS unrelated to NCWS or other types of
food “intolerance”, who were consecutively recruited during
the study period and sex- and age-matched with the NCWS
patients. IBS diagnosis had beenmade in accordance with the
Rome II criteria and none of these subjects improved on the
same elimination diet as the NCWS patients. They underwent
rectal mucosa biopsies when consuming a wheat containing
diet—a minimum of 100 g—for at least 4 weeks (median
8 weeks, range 4–24 weeks).
This study was approved by the Ethics Committee of the
University Hospital, Palermo, Italy where the patients were
recruited and all of them gave written informed consent for the
use and storage of tissue biopsies according to Declaration of
Helsinki principles. The study was registered at clinicaltrials.
gov (registration number: NCT01762579).
NCWS diagnosis. To diagnose NCWS, previously described
criteria were adopted21,22 (see Supplementary File S1).
Further inclusion criteria were: (a) age418 years; (b) follow-
up duration 46 months after the initial diagnosis; and (c) at
least two outpatient visits during the follow-up period.
Isolation of rectal mucosa infiltrating cells and
fluorescence-activated cell sorting analysis. Isolation of
rectal mucosa–infiltrating cells was performed according to
Carrasco et al.32 Briely, rectal biopsies were transferred in RPMI
1640 medium (Euroclone, Devon, UK) supplemented with
10% fetal calf serum (Euroclone), 2 mM L-glutamine (Euro-
clone), 20 mM HEPES (Euroclone), 100 U/ml penicillin (Euro-
clone), 100 μg/ml streptomycin (Euroclone), and 5×10−5 M
2-mercaptoethanol (Sigma, St Louis, MO) (complete medium).
Tissue was first minced into small pieces followed by enzymatic
digestion with 1.5 μg/ml type IV collagenase (Life Technologies,
Carlsbad, CA), 20 μg/ml hyaluronidase (Sigma), and 50 μg/ml
DNAase (Sigma) for 2 h at 37 °C.
After digestion, harvested cells were washed twice in fresh
complete medium and stained immediately or incubated
(106/ml) overnight at 37 °C in 5% CO2 for the functional assay
with medium alone, Ionomycin (1 μg/ml) and phorbol myristate
acetate (150 ng/ml) (Sigma) or with IL-12 (10 ng/ml), IL-15
(50 ng/ml), and IL-18 (15 ng/ml) (Sigma). For intracellular
analysis of cytokine expression, the Golgi blocker monensin
(10 mg/ml) (Sigma) was added to each condition. For charac-
terization of ILCs, cells freshly obtained from rectal tissue and
incubated overnight with the appropriate stimuli were stained
with the following fluorochrome-conjugated monoclonal anti-
bodies (mAbs): anti-CD45 (2D1, BD Biosciences, San Diego,
CA), anti-CD56 (MY31, BD Biosciences), anti-CD117
(YB5.B8, BD Biosciences), anti-NKp44 (P44-8, Biolegend,
San Diego, CA), anti-CD3 (SK7, BD Biosciences), anti-CD19
(SJ25C1, BD Biosciences), anti-CD14 (M5E2, BD Bio-
sciences), or with isotype-matched control mAbs (X40, BD
Biosciences) in incubation buffer (phosphate-buffered saline
(PBS) containing 1% fetal calf serum and 0.1% Na azide) for
30 min at 4 °C. The fixable viability dye 7-aminoactinomycin D
(Sigma) was added to gate-only live cells. Cells were washed
twice in PBS containing1% fetal calf serum, incubated for
30 min at 4 °C in a fixation/permeabilization solution (BD
Biosciences), and thereafter intracellular staining was per-
formed with anti-IFN-γ (B27, BD Biosciences), anti-TNF-α
(anti-tumor necrosis factor-α; 6401.1111, BD Biosciences),
anti-IL-22 (142928 R&D Systems, Minneapolis, MN), anti-
IL-17 (SCPL1362, BD Biosciences), anti-T-bet (H-210, Santa
Cruz Biotechnology, Dallas, TX), and isotype-matched control
mAbs (BD Biosciences). For T-bet detection, a purified primary
antibody incubation was followed by fluorescein isothio-
cyanate–conjugated goat anti-rabbit antibody (BD Biosciences,
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Table 1 Individual clinical characteristics of the 22 patients with NCWS included in the study
Case IBS
kind
Extraintestinal
symptoms
HLA
DQ2/DQ8,
yes/no
Duodenal
histology
AGA
IgG/IgA
Colon eos.
infiltration
CD
family
history
Associated
diseases
Other food
intolerances
1 IBS-A None DQ2 Marsh 1 Positives Yes No Allergic rhinitis Cow’s milk
2 IBS-D Oligomenorrhea
Headache
Tiredness
Foggy mind
Numbness
Oral aphtosis
DQ2 Marsh 1 Negatives Yes No None Cow’s milk
3 IBS-D Oral aphtous
Arthritis
DQ2 Marsh 1 Negatives No Yes Ankylosing
spondylitis
Hashimoto
disease
None
4 IBS-D None No Marsh 1 Negatives No No Sarcoidosis
Osteoporosis
Onion
5 IBS-C None No Marsh 0 Negatives No No Allergic rhinitis None
6 IBS-D Headache
Tiredness
Foggy mind
Numbness
Anaemia
DQ2 Marsh 1 Negatives No Yes None None
7 IBS-A Headache
Tiredness
Foggy mind
Numbness
Obesity
Oligomenorrhea
No Marsh 1 Positives No No None None
8 IBS-D None DQ2 Marsh 0 Negatives No No None Cow’s Milk
9 IBS-A Anemia
Dyspepsia
No Marsh 1 Positives Yes No Lichen planus Cow’s milk
10 IBS-D Hematochezia DQ2 Marsh 1 Negatives Yes No Asthma None
11 IBS-C Oligomenorrhea No Marsh 0 Negatives No No None None
12 IBS-A Artrhalgia
Sicca syndrome
DQ2 Marsh 1 Negatives Yes No Lichen Cow’s Milk, egg,
tomato, chocolate
13 IBS-D Anemia DQ2 Marsh 0 Negatives Yes Yes Allergic rhinitis
and asthma
Lactose
intolerance
Cow’s milk
14 IBS-C Anemia
Hypermenorrhea
Headache
Tiredness
Foggy mind
DQ2 Marsh 0 Negatives No No None None
15 IBS-D Headache
Tiredness
Foggy mind
Numbness
Artrhalgias
DQ8 Marsh 1 Negatives No No None None
16 IBS-D Polymenorrhea
Aphtosis
DQ2 Marsh 0 Negatives No Yes None Cow’s milk, egg
17 IBS-D None DQ2 Marsh 1 Negatives Yes No None Egg
18 IBS-A Vomit
Arthralgia
Raynaud
DQ2 Marsh 1 Negatives Yes No Orticaria Cow’s milk
19 IBS-A None DQ2 Marsh 1 Positives No No None Cow’s milk
20 IBS-A Anemia No Marsh 1 Positives No No None None
21 IBS-D Tiredness
Foggy mind
Numbness
Aphtosis
DQ2 Marsh 1 Negatives Yes No Recurrent
vaginitis
Cow’s milk
22 IBS-A None No Marsh 1 Positives No No None Cow’s milk
AGA, antigliadin antibodies; CD, celiac disease; eos., eosinophils; HLA, human leukocyte antigen; IBS, irritable bowel syndrome; IBS-A, IBS with alternating bowel
movements; I IBS-C, IBS-constipation; BS-D, IBS-diarrhea; IgA/IgG, immunoglobulin A/G; NCWS, non-celiac wheat-sensitivity.
Intraepithelial colon eosinophil infiltration was defined according to our previous study (reference 31) as: a number of eosinophils44 ×high power fields.
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San Diego, CA) staining. Samples were acquired on a
FACSCanto II (BD Biosciences) and analyzed using the FlowJo
software (Miltenyi Biotec, Cologne, Germany).
Immunofluorescence on paraffin-embedded tissue
sections. Rectal biopsies from NCWS patients and IBS
controls were fixed with formalin solution (Sigma) and embed-
ded in paraffin. Immunofluorescence staining was performed
on 5-μm-thick paraffin-embedded sections from tissue
samples. Following rehydration, antigens were unmasked
for 30 min at 95 °C using Dako Target retrieval solution
(Glostrup, Denmark; pH 6.0), and the sections were
incubated overnight at 4 °C with a purified mouse anti-CD3
(PC3/188A, Santa Cruz Biotechnology, 1:100 in PBS contain-
ing 3% bovine serum albumin and 0.05% Tween20). An
isotype-matched irrelevant antibody was used as a negative
control (ab27479, AbCam, Cambridge, UK).
Stained slides were then incubated with Cy5.5 goat anti-
mouse IgG (A10524, Life Technologies, 1:200 in PBS
containing 3% bovine serum albumin and 0.05% Tween20)
for 2 h at room temperature.
For the evaluation of intracellular molecules, sections
stained for surface molecules were then fixed with 2%
paraformaldehyde for 30 min and permeabilized with
Triton X -100 (BioRad, Hercules, CA) for 10 min. The purified
rabbit anti-human IFN-γ (Q69, Novus Biologicals Europe,
Abingdon Oxon, UK) was incubated 1:100 overnight at 4 °C
and then goat anti-rabbit Alexa fluor 555 (A21428, Invitrogen,
Carlsbad, CA) was added to the sections for 2 h. Stained slides
were fixed with 2% paraformaldehyde for 30 min and then
incubated for 3 h with purified rabbit anti-T-bet (H-210, Santa
Cruz Biotechnology, 1:50). Positivity for T-bet was detected by
incubation for 2 h with goat anti-rabbit Alexa fluor 488 (A11008,
Life Technologies) in the presence of 200 ng/ml RNAse
(Sigma). An isotype-matched polyclonal antibody (rabbit IgG
ab27472, Abcam) was used as a negative control for
intracellular staining. Finally, nuclei were counterstained with
DAPI (4,6-diamidino-2-phenylindole; Sigma), and imageswere
acquired using a confocal laser-scanning microscope (Leica
Microsystems, Milan, Italy). Multiple cells were analyzed for
each staining condition, with × 40 and ×63 magnifications.
Statistical analysis. Data were analyzed for statistical
significance using Mann–Whitney test for two groups and
Kruskal–Wallis test for more than two groups. Differences
between groups with a probability of ≤0.05 were regarded as
significant. All data were analyzed using GraphPad Prism
version 6.0e (GraphPad, San Diego, CA).
RESULTS
We challenged 22 NCWS patients, all on a gluten-free diet, as
described under Methods section and collected rectal biopsy
specimens at the end of challenge when they reported the
Figure 1 Leukocyte infiltration and cytokine expression in rectal biopsies of non-celiac wheat-sensitive (NCWS) patients on wheat challenge. (a) Mean percentages
of leukocytes (live CD45+ cells) infiltrating the rectal tissue of NCWS patients on wheat challenge and irritable bowel syndrome (IBS) controls. (b) Percentage of CD45+ cells and
(c) percentage of CD3− cells expressing different cytokines in the rectal mucosa of NCWS patients on wheat challenge and IBS controls. Data are expressed as mean± s.e.m.
*Po0.05. (d) Representative dot plots showing the expression of several cytokines by CD3+ and CD3− subsets of CD45+ cells infiltrating the rectal mucosa of IBS controls (upper
panel) and NCWS patients on wheat challenge (upper panel). IFN, interferon; IL, interleukin; TNF, tumor necrosis factor; 7AAD, 7-aminoactinomycin D.
Role of ILC1 in NCWS Pathogenesis
Di Liberto et al.
4
Clinical and Translational Gastroenterology
reappearance of the symptoms. Single-cell suspensions were
obtained from the specimens and were examined for cytokine
expression by intracellular fluorescence-activated cell sorting
analysis and compared with specimen samples from patients
with IBS unrelated to NCWS or other types of food intolerance
and who did not improve on wheat-free diet. As shown in
Figure 1a, rectal biopsies from NCWS patients on wheat
challenge had a relevant CD45+ leukocyte infiltrate (7.99±
1.035%) comparable to that detected in IBS controls who
did not improve on elimination diet (6.85± 1.206%). The
infiltrating CD45+ cells from NCWS patients spontaneously
expressed IFN-γ and the percentages of CD45+IFN-γ+ cells
were significantly higher than those detected in IBS patients.
We also found that CD45+ cells from NCWS patients
spontaneously expressed TNF-α, IL-17, and IL-22, but at
lower levels than IFN-γ, even if percentages were not
statistically significant compared with those detected in IBS
patients (Figure 1b).
The finding that IFN-γ expressionwas upregulated in human
NCWS tissues after gluten challenge prompted us to
investigate the source of this cytokine. We found that the
major IFN-γ-producing cells were CD3+ and CD14+ cells,
which were also the major source of TNF-α, IL-17, and IL-22
(data not shown). Interestingly, additional analyses of CD45+
infiltrating the rectal mucosa of wheat-challenged patients
highlighted a significantly higher frequency of CD3−CD14−
cells (Figure 1c) producing IFN-γ (2.6±0.9% of CD45+ cells),
compared with IBS controls (0.8± 0.4% of CD45+ cells)
(Po0.05; Figure 1c). Of note, this CD3−CD14− fraction
accounted for about one-third (32%) of all CD45+IFN-γ+ cells.
Figure 1d shows representative results from one NCWS
patient and one IBS control.
We next examined the characteristics of the CD45+
CD3−CD14− population expressing IFN-γ+ in tissues from
NCWS patients. As shown in Figure 2a, the whole infiltrating
IFN-γ+ CD45+CD3−CD14− cells had a T-bet+, CD56−,
NKP44−, and CD117− phenotype, indicating that these
cells are ILC1 and are not classical NK cells. ILC1 were
similarly present in the rectal mucosa of IBS controls,
but overall frequencies were significantly lower (only about
Figure 2 Type-1 innate lymphoid cells (ILC1) infiltrate the inflamed rectal mucosa of non-celiac wheat-sensitive (NCWS) patients upon wheat challenge. (a) Representative
dot plots showing the gating strategy for the ex vivo identification and characterization of ILC1 in the rectal mucosa of NCWS patients. (b) Representative images of confocal
analysis of T-bet (green), interferon (IFN)-γ (red), and negative CD3 (cyan) co-localization in the rectal mucosa of a wheat-challenged NCWS patient (upper panel) and of an
irritable bowel syndrome (IBS) control (lower panel). The merge panels show triple staining of the analyzed ILC1. Nuclei were counterstained with DAPI (4,6-diamidino-2-
phenylindole). (c) IFN-γ production by ILC1 infiltrating the rectal mucosa of a NCWS patient and cultured for 24 h either alone (medium) or with Ionomycin/phorbol myristate
acetate (PMA) or with a combination of interleukin (IL)-12, IL-15, and IL-18. 7AAD, 7-aminoactinomycin D.
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3% of these cells were T-bet+ in IBS controls) than in NCWS
patients upon challenge (about 15% of these cells were
T-bet+).
Figure 2b shows confocal microscopic analysis of the
IFN-γ+ cells that infiltrated the rectal mucosa of a representa-
tive NCWS patient on wheat challenge and an IBS control:
cells were detected as simultaneously positive for nuclear
expression of T-bet and cytosolic expression of IFN-γ but
negative for surface expression of CD3.
Functional experiments confirmed that the IFN-γ+ CD45+
CD3−CD14− cell population infiltrating tissues from NCWS
patients was in fact ILC1, as culture of these cells with IL-12,
IL-15, and IL-18 triggered sixfold more IFN-γ production
compared with culture with medium alone (81% vs. 15.6%),
and even threefold more IFN-γ production compared with
stimulation with Ionomycin–phorbol myristate acetate
(81% vs. 31%) (Figure 2c).
To determine whether infiltrating ILC1 cells were correlated
with the pathogenesis of NCWS, we retested 10 NCWS
patients 2 weeks after they resumed a wheat-free diet, when
they again became asymptomatic. Of these, 5 cases belonged
to the 22 patients already studied on wheat challenge and
who agreed to repeat the mucosal study and 5 cases were
not previously studied.
As shown in Figure 3, NCWS patients on wheat-free
diet (10 cases) showed a significantly lower frequency of
infiltrating IFN-γ-producing CD45+ and their CD3−CD14−
fraction (Po0.01; Figure 3a), which was evident in all
the 5 NCWS patients already studied on wheat challenge
(Figure 3b). Accordingly, the frequency of ILC1 signifi-
cantly decreased after wheat-free diet, when compared with
wheat-challenged patients, as shown by cumulative data
reported in Figure 3c and data from one individual patient
(Figure 3d).
DISCUSSION
Despite some residual skepticism, NCWS is emerging as a
new clinical entity, although it is not yet well defined. The
hypothesis that it is a heterogeneous condition and that people
suffering from NCWS can be symptomatic due to different
pathogenic mechanisms—not exclusively dependent on
Figure 3 Effect of wheat-free diet on type-1 innate lymphoid cells (ILC1) infiltrating the rectal mucosa. (a) Percentages of cytokine-producing CD45+ cells and CD3− cells
infiltrating the rectal mucosa of non-celiac wheat-sensitive (NCWS) patients on wheat challenge and after wheat-free diet. Data are expressed as mean± s.e.m. *Po0.05;
**Po0.01 (Mann–Whitney test). (b) Percentages of cytokine-producing CD3− cells infiltrating the rectal mucosa of five individual NCWS patients on wheat challenge and after
wheat-free diet. (c) ILC1 before (or on wheat challenge) and after wheat-free diet in NCWS patients. Data are shown as mean percentage± s.e.m. *Po0.05. (d) Representative
dot plots showing the percentage of ILC1 in irritable bowel syndrome (IBS) control (upper panel) and NCWS patients on wheat challenge (middle panel) and after wheat-free diet
(lower panel). FSC, forward scatter; IFN, interferon; SSC, side scatter; 7AAD, 7-aminoactinomycin D.
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gluten ingestion—should be acknowledged, as suggested by
many authors.5,31,33–38
Recently we contributed data supporting an immunological
effect of wheat ingestion,33 showing that NCWS patients have
a strong tendency to autoimmunity, characterized by both
associated autoimmune diseases and the presence of serum
antinuclear antibodies positivity.34
However, very little is known about the immunological
mechanism that starts in the intestinal mucosa as a conse-
quence of wheat ingestion. Both innate8,9 and adaptive
immunity10,11,39 have been suggested as being involved in
the immunological response of NCWS patients. Further-
more, experimental data showed that a component of wheat,
amylase trypsin inhibitors, acts as potent stimulators of innate
immune reactions by the stimulation of Toll-like receptor 4 in
monocytes, macrophages, and dendritic cells.40
Our data strongly support the role of innate immunity in
the pathogenesis of NCWS. We demonstrated a signifi-
cant infiltration of CD45+/CD3−CD14− cells in the rectal
mucosa of NCWS patients upon wheat challenge. Analysis
of cytokine production demonstrated dominant sponta-
neous IFN-γ production by these cells, which were further
identified as an ILC1 population expressing T-bet and
producing IFN-γ.
A possible role for IFN-γ production in NCWS was also
demonstrated in a Norwegian study,10 but authors also
reported an increased infiltration of CD3+ T cells in the patient
duodenal mucosa. In our study, we also detected CD3+ cells in
the rectal mucosa of NCWS patients (data not shown), and
studies are ongoing in our laboratories to identify their
phenotypic and functional characteristics. However, the
original feature of our study was the finding of ILC1 cells
among infiltrating leukocytes, which decreased on wheat-free
diet, indicating that they are involved in the pathogenesis
of NCWS.
Innate lymphocytes are actually divided into three major
groups on the basis of different transcriptional control and
cytokine responsiveness and production: ILC1 are under
control of the T-bet transcription factor and produce IFN-γ
in response to IL-12, IL-15, or IL-18 stimulation.23,41 Their
functional response was also demonstrated in the experi-
ments that we performed on the ILC1 cell population of
the rectal mucosa of NCWS patients included in the
present study.
We focused on the colon and not on the duodenalmucosa of
NCWSpatients as the patients included in the present study—
as most of those included in the previous studies published
recently—suffered from IBS-like symptoms and it is well
known that IBS is very often characterized by colon mucosa
inflammation.42–44 Consequently and in agreement with our
unpublished data, we hypothesized that the immunological
response could be more prominent in the colon rather than in
the duodenal mucosa of NCWS patients.
However, the unique previous study that looked at the colon
mucosa of NCWS patients did not show any difference in
CD4+, CD68+, CD79+ lymphocyte infiltration during gluten-
free and gluten-containing diet, but only significant decreases
in the expression of zonula occludens 1, claudin-1, and
occludin in rectosigmoid mucosa was demonstrated on
gluten-containing diet.11
The limits of our study must be noted. First, we studied
patients referred to tertiary centers with experience in Crohn’s
disease and NCWS and this factor clearly led to a selection
bias: therefore, our results cannot be extended to the
broad population of self-treated or self-diagnosed NCWS
patients. Moreover, a small patient samplewas studied andwe
agree that a percentage of self-reported NCWS patients did
not have an immunological mechanism as the basis of their
symptoms.
Second, we cannot actually exclude a role for adaptive
immunity in NCWS pathogenesis, although not demonstrated
in the present study. Our current working hypothesis is that
adaptive immunity could have a very relevant role in a “second
pathogenic phase”. The exact role for the mucosal eosinophil
infiltrate that we had shown in both the duodenal and colon
mucosa of NCWS patients31,34 or mast cells remains to be
clarified.
Finally, our study did not look at the duodenal mucosa and
we are not able to give data on this site.
On the other hand, we show a clear-cut innate immuno-
logical activation in patients suffering from NCWS and
diagnosed by DBPC wheat challenge. The significant
reduction in ILC1 after wheat-free diet in all the patients
who underwent rectal biopsies after wheat was withdrawn
from the diet indicates a close correlation between adminis-
tration of foods containing wheat, expansion of ILC1,
and NCWS and suggests a therapeutic role for a wheat-
free diet.
In conclusion, our data indicate that, in people with active
NCWS, ILC1 infiltrate their rectal mucosa and express
transcripts encoding the pro-inflammatory cytokine IFN-γ,
supporting a role for this lymphoid cell subset in the
pathogenesis of NCWS.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ Non-celiac wheat sensitivity (NCWS) is a condition where
intestinal and extraintestinal symptoms are triggered by wheat
ingestion in the absence of celiac disease and wheat allergy.
✓ NCWS pathogenesis has been attributed to very different
mechanisms: incomplete digestion and/or absorption of
FODMAPs, psychological effect, or innateor adaptive immunity.
A clear pathogenetic role for the immunesystem is still debated.
✓ Relevant alterations in intestinal innate lymphoid cells
(ILCs) have been detected in patients with inflammatory
bowel disease.
WHAT IS NEW HERE
✓ Intraepithelial IFN-γ+ ILC1 cells are expanded in the
inflamed rectal tissue of NCWS patients.
✓ Their values significantly decrease after wheat-free diet,
suggesting that intraepithelial ILC1 may initiate IFN-γ
response and contribute to the pathogenesis of NCWS.
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